• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • James A. Bonner, Paul M. Harari, +10 authors Kian K. Ang
  • Medicine
  • The Lancet. Oncology
  • 2010
  • BACKGROUND Previous results from our phase 3 randomised trial showed that adding cetuximab to primary radiotherapy increased overall survival in patients with locoregionally advanced squamous-cellExpand
  • S M Huang, Paul M. Harari
  • Biology, Medicine
  • Clinical cancer research : an official journal of…
  • 2000 (First Publication: 1 June 2000)
  • We have recently demonstrated that molecular blockade of the epidermal growth factor receptor with the anti-epidermal growth factor receptor (EGFR) monoclonal antibody C225 enhances the in vitroExpand
  • Shyhmin Huang, Jonathan M. Bock, Paul M. Harari
  • Biology, Medicine
  • Cancer research
  • 1999 (First Publication: 15 April 1999)
  • We examined effects of the anti-epidermal growth factor receptor monoclonal antibody C225 on proliferation, cell cycle phase distribution, apoptosis, and radiosensitivity in squamous cell carcinomaExpand
  • Desmond Curran, Jordi Giralt, +9 authors James A. Bonner
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2007 (First Publication: 1 June 2007)
  • PURPOSE In this randomized, phase III study, quality of life (QoL) was assessed in patients with locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN) after high-doseExpand